Cargando…

Pharmacy Students’ Perceptions and Stigma Surrounding Naloxone Use in Patients with Opioid Use Disorder: A Mixed Methods Evaluation

Pharmacists represent a key group of healthcare professionals that can increase awareness and destigmatize naloxone use. The objective of this study was to investigate pharmacy student perceptions of the use, dispensing, and stigma surrounding naloxone. An electronic survey was administered to pharm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cernasev, Alina, Veve, Michael P., Talbott, Taylor, Hall, Elizabeth A., Hohmeier, Kenneth C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712231/ https://www.ncbi.nlm.nih.gov/pubmed/33153144 http://dx.doi.org/10.3390/pharmacy8040205

Ejemplares similares

Stigma of Opioid Use Disorder and Its Indirect Effects on Student Pharmacists’ Perceptions and Attitudes
por: Hall, Elizabeth A., et al.
Publicado: (2020)

“Don’t Label Them as Addicts!” Student Pharmacists’ Views on the Stigma Associated with Opioid use Disorder
por: Cernasev, Alina, et al.
Publicado: (2021)

Pharmacy Technicians, Stigma, and Compassion Fatigue: Front-Line Perspectives of Pharmacy and the US Opioid Epidemic
por: Cernasev, Alina, et al.
Publicado: (2021)

Student Perceptions of Substance Use Disorder Stigma as a Factor for Health Disparities: A Mixed-Methods Study
por: Barenie, Rachel E., et al.
Publicado: (2023)

Importance of pharmacist-patient relationship in people living with HIV and concomitant opioid use disorder
por: Cernasev, Alina, et al.
Publicado: (2021)

Faculty, staff, and student perceptions of substance use disorder stigma in health profession training programs: a quantitative study
por: Barenie, Rachel E., et al.
Publicado: (2023)

U.S. student pharmacist perceptions of the pharmacist’s role in methadone for opioid use disorder: A qualitative study
por: Hohmeier, Kenneth C, et al.
Publicado: (2021)

Healthcare Professional Students’ Perspectives on Substance Use Disorders and Stigma: A Qualitative Study
por: Cernasev, Alina, et al.
Publicado: (2022)

A systematic literature review of patient perspectives of barriers and facilitators to access, adherence, stigma, and persistence to treatment for substance use disorder
por: Cernasev, Alina, et al.
Publicado: (2021)

Podcasts as a Method to Deliver Education on Stigma Surrounding Opioid Use Disorder
por: Kissell, Logan M., et al.
Publicado: (2022)

Patient reported goals for medications for opioid use disorder: A theory of proximal goal attainment
por: Hohmeier, Kenneth C., et al.
Publicado: (2023)

Orienting patients to greater opioid safety: models of community pharmacy-based naloxone
por: Green, Traci C., et al.
Publicado: (2015)

Community-Centered Patient Journey Map in Opioid Use Disorder: A Tool to Address Compassion Fatigue among Community Pharmacists
por: Hohmeier, Kenneth Charles, et al.
Publicado: (2023)

If we build it, will they come? Perspectives on pharmacy-based naloxone among family and friends of people who use opioids: a mixed methods study
por: Slocum, Susannah, et al.
Publicado: (2022)

Opioid Use Disorders in People Living with HIV/AIDS: A Review of Implications for Patient Outcomes, Drug Interactions, and Neurocognitive Disorders
por: Cernasev, Alina, et al.
Publicado: (2020)

Opioid overdose counseling and prescribing of naloxone in rural community pharmacies: A pilot study
por: Teeter, Benjamin S., et al.
Publicado: (2021)

Reducing the stigma surrounding opioid use disorder: evaluating an opioid overdose prevention training program applied to a diverse population
por: Bascou, Nicholas Alexander, et al.
Publicado: (2022)

Increasing proactive co-dispensing of take-home naloxone with prescription opioids at Ontario community pharmacies
por: Qiu Hua Chen, Autumn
Publicado: (2022)

The status of naloxone in community pharmacies across Canada
por: So, Randy, et al.
Publicado: (2020)

Stakeholders’ Perceptions of Factors Influencing the Use of Take-Home-Naloxone
por: Holland, Taylor J., et al.
Publicado: (2020)

Public perceptions of naloxone use in the outpatient setting
por: Smith, Jordan O., et al.
Publicado: (2019)

Naloxone for opioid toxicity and overdose in the community
por: Jauncey, Marianne, et al.
Publicado: (2021)

Public Perceptions of Community Pharmacy-Based Naloxone Services: A National Cross-Sectional Survey
por: Hohmann, Lindsey A., et al.
Publicado: (2022)

Naloxone availability in independent community pharmacies in Georgia, 2019
por: Gilbert, Lauren, et al.
Publicado: (2021)

Perspectives Associated with Human Papillomavirus Vaccination in Adults: A Qualitative Study
por: Cernasev, Alina, et al.
Publicado: (2023)

Empowering Tennessee Pharmacists to Initiate PrEP Using Collaborative Pharmacy Practice Agreements
por: Cernasev, Alina, et al.
Publicado: (2023)

Effectiveness of an Advanced Naloxone Training, Simulation, and Assessment of Second-Year Pharmacy Students
por: Courtney, Jennifer, et al.
Publicado: (2022)

The role of increasing pharmacy and community distributed naloxone in the opioid overdose epidemic in Massachusetts, Rhode Island, and New York City()
por: Morgan, Jake R., et al.
Publicado: (2022)

Mixed methods feasibility study for the surviving opioid overdose with naloxone education and resuscitation (SOONER) trial
por: Orkin, Aaron M., et al.
Publicado: (2021)

Assessment of the safety and ease of use of the naloxone auto-injector for the reversal of opioid overdose
por: Merlin, Mark A, et al.
Publicado: (2015)

An Evaluation of Naloxone Use for Opioid Overdoses in West Virginia: A Literature Review
por: Beheshti, Annahita, et al.
Publicado: (2015)

Opioid overdose and naloxone education in a substance use disorder treatment program
por: Lott, David C., et al.
Publicado: (2016)

Practical implications of naloxone knowledge among suburban people who use opioids
por: Schneider, Kristin E., et al.
Publicado: (2021)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Superusers experiences in using naloxone to reverse opioid overdose - A qualitative study
por: Troberg, K., et al.
Publicado: (2022)

Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients
por: Amaducci, Alexandra, et al.
Publicado: (2023)

Will converting naloxone to over‐the‐counter status increase pharmacy sales?
por: Murphy, Sean M., et al.
Publicado: (2019)

Opioid Drug Utilization and Cost Outcomes Associated With the Use of Buprenorphine-Naloxone in Patients With a History of Prescription Opioid Use
por: Kaur, Aman Deep, et al.
Publicado: (2008)

The Lean Six Sigma Define, Measure, Analyze, Implement, Control (LSS DMAIC) Framework: An Innovative Strategy for Quality Improvement of Pharmacist Vaccine Recommendations in Community Pharmacy
por: Hohmeier, Kenneth C., et al.
Publicado: (2022)

From controlled opioid substitution treatment to pharmacy delivery of buprenorphine-naloxone and to treatment in primary health care: the views of patients and personnel
por: Tourunen, Jouni, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_iqj3rekhu8t853mckqm9kmi2ia